AptarGroup, Inc. (ATR) Stock
ATR Key Statistics
About AptarGroup, Inc.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
CEO: Gael Touya. Company website
ATR — Frequently Asked Questions
What is the ATR stock price today?
AptarGroup, Inc. (ATR) trades at $143.08, down 0.72% on the day, as of Nov 12, 2026 09:30 UTC.
What is AptarGroup, Inc.'s market cap?
AptarGroup, Inc. has a market capitalisation of $9.07B, calculated from the live ATR share price and shares outstanding.
What is the P/E ratio of ATR?
ATR trades at a trailing P/E of 34.72, from earnings per share of $4.12 over the last twelve months.
How much revenue does AptarGroup, Inc. make?
AptarGroup, Inc. generated revenue of $3.99B over the trailing twelve months, which puts the stock at 2.27 times sales.
Does ATR pay a dividend?
Yes. AptarGroup, Inc. pays a dividend yielding 1.45% on the current share price.
What is the 52-week range for ATR?
ATR has traded between $110.95 and $148.63 over the past 52 weeks, and the last price is 3.7% below that high.
Is AptarGroup, Inc. profitable?
Yes. AptarGroup, Inc. keeps 6.69% of revenue as net income over the trailing twelve months.
What is the analyst price target for ATR?
Wall Street analysts rate ATR Buy, with an average price target of $148.33, 3.7% above the current price.
What sector is AptarGroup, Inc. in?
AptarGroup, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of AptarGroup, Inc.?
Gael Touya is the chief executive of AptarGroup, Inc., which employs 14,000 people.
Where can I track ATR in real time?
QFI Terminal shows ATR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ATR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ATR in Terminal See plans